Kaveh Barami1, Jessica Pemberton2, Amit Banerjee3, Jason London4, William Bandy2. 1. Department of Neurosurgery, Kaiser Vacaville, Vacaville, CA. 2. Department of Trauma Surgery, Kaiser Vacaville, Vacaville, CA. 3. Department of Neurosurgery, Kaiser Sacramento, Sacramento, CA. 4. Department of Trauma Surgery, Kaiser South Sacramento, Sacramento, CA.
Abstract
BACKGROUND: The role of intracranial pressure (ICP) monitoring in improving outcomes after severe traumatic brain injury especially at level II trauma centers remains controversial. A retrospective analysis was undertaken to assess the impact of ICP monitoring on mortality and long-term functional outcome in adults after severe traumatic brain injury at level II trauma centers. METHODS: The data were extracted from the Kaiser Permanente trauma database. Inclusion criteria were adults (≥ 18 years) with severe traumatic brain injury (Glasgow Coma Scale score, < 9) admitted to 2 level II trauma centers in Northern California from 2014 to 2019. RESULTS: Of 199 patients, 58 (29.1%) underwent ICP monitoring. The monitored subgroup was significantly younger (< 65 years), had lower Glasgow Coma Scale scores (3-5), underwent cranial procedures (craniotomy or decompressive craniectomy) more often, and had greater injury severity scores (≥ 15). Despite monitored patients being more severely injured, there was no significant difference in mortality or 6-month favorable outcomes between monitored and nonmonitored patients, including patients who underwent cranial procedures. Increased monitoring frequency and reduction in overall mortality was seen throughout the study period yet with a parallel reduction in both groups. CONCLUSION: ICP monitoring may not impact in-patient mortality or long-term outcomes at level II trauma centers. Improved outcomes may be more related to identifying patients who may benefit from ICP-guided therapy rather than simply increasing the overall use of it. Last, our pattern of care and outcomes are comparable to level I trauma centers and our findings may serve as a benchmark for future studies.
BACKGROUND: The role of intracranial pressure (ICP) monitoring in improving outcomes after severe traumatic brain injury especially at level II trauma centers remains controversial. A retrospective analysis was undertaken to assess the impact of ICP monitoring on mortality and long-term functional outcome in adults after severe traumatic brain injury at level II trauma centers. METHODS: The data were extracted from the Kaiser Permanente trauma database. Inclusion criteria were adults (≥ 18 years) with severe traumatic brain injury (Glasgow Coma Scale score, < 9) admitted to 2 level II trauma centers in Northern California from 2014 to 2019. RESULTS: Of 199 patients, 58 (29.1%) underwent ICP monitoring. The monitored subgroup was significantly younger (< 65 years), had lower Glasgow Coma Scale scores (3-5), underwent cranial procedures (craniotomy or decompressive craniectomy) more often, and had greater injury severity scores (≥ 15). Despite monitored patients being more severely injured, there was no significant difference in mortality or 6-month favorable outcomes between monitored and nonmonitored patients, including patients who underwent cranial procedures. Increased monitoring frequency and reduction in overall mortality was seen throughout the study period yet with a parallel reduction in both groups. CONCLUSION: ICP monitoring may not impact in-patient mortality or long-term outcomes at level II trauma centers. Improved outcomes may be more related to identifying patients who may benefit from ICP-guided therapy rather than simply increasing the overall use of it. Last, our pattern of care and outcomes are comparable to level I trauma centers and our findings may serve as a benchmark for future studies.
Authors: A L Falcão; V P Dantas Filho; L A Sardinha; E M Quagliato; D Dragosavac; S Araújo; R G Terzi Journal: Arq Neuropsiquiatr Date: 1995-09 Impact factor: 1.420
Authors: Victor Volovici; Jilske A Huijben; Ari Ercole; Nino Stocchetti; Clemens M F Dirven; Mathieu van der Jagt; Ewout W Steyerberg; Hester F Lingsma; David K Menon; Andrew I R Maas; Iain K Haitsma Journal: J Neurotrauma Date: 2018-10-30 Impact factor: 5.269
Authors: E Sorrentino; J Diedler; M Kasprowicz; K P Budohoski; C Haubrich; P Smielewski; J G Outtrim; A Manktelow; P J Hutchinson; J D Pickard; D K Menon; M Czosnyka Journal: Neurocrit Care Date: 2012-04 Impact factor: 3.210